Product
Oral Blood Glucose Lowering Drugs
1 clinical trial
3 indications
Indication
efficacyIndication
SafetyIndication
TolerabilityClinical trial
Efficacy, Safety & Tolerability of Combination of Ertugliflozin and Sitagliptin in Patients With Type II Diabetes MellitusStatus: Recruiting, Estimated PCD: 2023-12-01